Texas Department of Transportation Executive Director after sitting in the production version of @Tesla’s Cybercab:
"The complete absence of traditional driver controls underscores a significant shift in mobility and vehicle design. No steering wheel, no accelerator, no brake. Only a single touch-screen monitor.
Tesla is now operating Robotaxis (using Model Ys) around Austin, Dallas and Houston in Full Self Driving mode. The introduction of the Cybercab will dramitically scale these operations over the coming months."
.@elonmusk told me he plans to build “Optimus Academy” to train an army of humanoid robots.
> “millions of simulated robots in the simulated world”
> “tens of thousands of robots in the real world, to close the simulation to reality gap.”
Why? There’s two big differences between the way Tesla will train humanoid robots and the way it built Full Self-Driving.
- FSD only requires learning three degrees of freedom: turning, accelerating, braking … and a humanoid robot has to learn how to coordinate 50+ joints.
- You can sell a Tesla without FSD, which allows you to collect the millions and millions of hours of driving data needed to bootstrap your model ... but you can’t sell an Optimus that hasn’t learned how to do stuff yet.
The Optimus Academy is Elon’s attempt to build the data flywheel that Tesla got for free with FSD.
Elon Musk: "I kind of agree with Ark Invest and Cathie Wood that autonomy, robotic taxis, makes Tesla about a $5 trillion company. The Optimus robot, I think, makes Tesla a $25 trillion company."
Fable isn't the first.
In 1999 the department of defense blocked exports of the PowerMac G4 for crossing the 1 gigaflop threshold.
Steve Jobs turned it into an ad.
BREAKING: Solar energy accounted for 12.8% of US electricity production in May, surpassing coal at 12.2%, marking the first time this has occurred in a full calendar month.
Solar generation surged +17.0% YoY in May while coal output declined -11.0%, continuing a historic shift in the US power mix.
This shift has been supported by years of rapid solar deployment, while rising electricity demand from AI data centers further boosting investment in new generation capacity.
As a result, solar and battery storage together accounted for 91% of all new US power capacity installed in Q1 2026.
Meanwhile, natural gas remains the dominant source at 37% of the US electricity mix.
The AI revolution is accelerating America's energy transition.
Google and Microsoft now have a combined AI backlog of more than $1 Trillion
- Google $GOOGL now has a $467.6 Billion revenue backlog up from $92.4B in the same quarter last year
- Microsoft $MSFT now has a $633B revenue backlog up from $321B in the same quarter last year
Lung cancer remains the leading cause of cancer-related death in the United States. A promising new development could help change that trajectory.
BioNTech has launched human clinical trials for BNT116, the world’s first mRNA-based therapeutic vaccine specifically designed for non-small cell lung cancer (NSCLC), the most common and deadliest form of the disease. Using the same mRNA technology proven effective in COVID-19 vaccines, BNT116 delivers genetic instructions to train the patient’s immune system to recognize and attack tumor cells expressing specific tumor-associated antigens, while largely sparing healthy tissue.
The Phase 1 trial (LuCa-MERIT-1 / NCT05142189) is actively recruiting across multiple sites in seven countries, including the United States and the United Kingdom. It is evaluating BNT116 both as a monotherapy and in combination with immunotherapy (such as cemiplimab) and chemotherapy. The vaccine is administered in weekly doses followed by maintenance injections. Early participants, including 67-year-old Janusz Racz in London, have already begun treatment. Researchers hope the approach will not only shrink existing tumors but also help prevent recurrence.
This personalized immunotherapy represents a major step toward more targeted and less toxic treatments for lung cancer.
[BioNTech. (Ongoing). Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-Small Cell Lung Cancer (BNT116-01; NCT05142189)]
🇺🇸Google's next product launch is 32 million mosquitoes.
California and Florida are the test markets.
The goal is disease control through mass sterile mosquito release, a proven method, but this is the first time a tech giant has deployed it at this scale.
Google went from fixing bugs to releasing them.
Source: 10 Tampa Bay News (WTSP)
Insane stat of the day: California almonds use roughly 3–5.5 million acre-feet of water per year, depending on methodology.
That's ~4-7x more water than all data centers in North America used combined in 2025.